Skip to content Skip to footer

Advancing Oncology Therapeutics Through Biosimilar Innovation

At LOKA Biosciences, we combine cutting-edge biotechnology with cGMP-certified manufacturing to deliver safe, effective, and globally trusted oncology biosimilars

Biosimilars at LOKA

Biosimilars are next-generation biological medicines that make advanced treatments more accessible and affordable. Designed to be highly comparable to their reference biologics, they meet the highest standards of safety, purity, and potency, ensuring patients receive the same trusted benefits as the original therapies.

At LOKA Biosciences, we are proud to be at the forefront of indigenous biosimilar development and manufacturing. Our state-of-the-art cGMP-certified facility in Hyderabad, India, is dedicated to delivering world-class oncology biosimilars that combine quality, affordability, and reliability.

Our Oncology Biosimilars Portfolio

• L-Asparaginase API

Injectable, pharmaceutical-grade; manufactured to global quality standards for oncology applications.

• PEG L-Asparaginase

Ready-to-fill, pharmaceutical-grade; developed for enhanced stability, patient convenience, and treatment outcomes.